Yonsei Med J.  2013 Sep;54(5):1293-1296. 10.3349/ymj.2013.54.5.1293.

Familial Occurrence of Pulmonary Embolism after Intravenous, Adipose Tissue-Derived Stem Cell Therapy

• Jung JW
• Kwon M
• Choi JC
• Shin JW
• Park IW
• Choi BW
• Kim JY

• KMID: 1793183
• DOI: http://doi.org/10.3349/ymj.2013.54.5.1293

Abstract

The therapeutic potential of human multipotent mesenchymal stromal cells, especially human adipose tissue-derived stem cells (hASC), is promising. However, there are concerns about the safety of infusion of hASC in human. Recently, we have experienced pulmonary embolism and infarct among family members who have taken multiple infusions of intravenous autologous hASC therapy. A 41-year-old man presented with chest pain for one month. Chest CT showed multiple pulmonary artery embolism and infarct at right lung. Serum D-dimer was 0.8 microg/mL (normal; 0-0.5 microg/mL). He had received intravenous autologous adipose tissue-derived stem cell therapy for cervical herniated intervertebral disc three times (one, two, and three months prior to the visit). His parents also received the same therapy five times and their chest CT also showed multiple pulmonary embolism. These cases represent artificial pulmonary embolisms and infarct after IV injection of hASC. Follow-up chest CT showed spontaneous resolution of lesions in all three patients.

Keyword

Stem cell; pulmonary embolism; infarct; family

MeSH Terms

Adipose Tissue/cytology
Adult
Cell- and Tissue-Based Therapy/*adverse effects
Female
Humans
Male
Mesenchymal Stem Cell Transplantation/*adverse effects
Pulmonary Embolism/*etiology/radiography
Pulmonary Infarction/etiology/radiography
Tomography, X-Ray Computed

Figure

• 

  Fig. 1 Chest CT of patient. (A) Chest CT demonstrates wedge-shaped, peripheral consolidation at upper lobe of right lung (black arrow), which is consistent with pulmonary infarct. (B) Chest CT shows multiple filling defects (white arrows) at segmental pulmonary artery branches of right lung along with right pleural effusion (black arrow head). (C) Follow-up chest CT taken three month later showed disappearance of pleural effusion and pulmonary emboli.

• 

  Fig. 2 Chest CT of his father (A) revealed multiple emboli at segmental pulmonary artery branch (white arrow head) and right pleural effusion (white arrow). Chest CT of his mother (B) showed linear emboli (white arrow) along the lumen of pulmonary artery branch of right lung.

Reference

1. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature. 2012; 481:295–305.

2. Shen JF, Sugawara A, Yamashita J, Ogura H, Sato S. Dedifferentiated fat cells: an alternative source of adult multipotent cells from the adipose tissues. Int J Oral Sci. 2011; 3:117–124.

3. Sensebé L, Bourin P. Mesenchymal stem cells for therapeutic purposes. Transplantation. 2009; 87:9 Suppl. S49–S53.

4. Parker AM, Katz AJ. Adipose-derived stem cells for the regeneration of damaged tissues. Expert Opin Biol Ther. 2006; 6:567–578.

5. Brignier AC, Gewirtz AM. Embryonic and adult stem cell therapy. J Allergy Clin Immunol. 2010; 125:2 Suppl 2. S336–S344.

6. Erickson GR, Gimble JM, Franklin DM, Rice HE, Awad H, Guilak F. Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun. 2002; 290:763–769.

7. Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H, et al. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum. 2003; 48:418–429.

8. Black LL, Gaynor J, Adams C, Dhupa S, Sams AE, Taylor R, et al. Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther. 2008; 9:192–200.

9. Black LL, Gaynor J, Gahring D, Adams C, Aron D, Harman S, et al. Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet Ther. 2007; 8:272–284.

10. Cyranoski D. Korean deaths spark inquiry. Nature. 2010; 468:485.

11. Takahashi Y, Tsuji O, Kumagai G, Hara CM, Okano HJ, Miyawaki A, et al. Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice. Cell Transplant. 2011; 20:727–739.

12. Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res. 2009; 77:370–376.

13. Tatsumi K, Ohashi K, Matsubara Y, Kohori A, Ohno T, Kakidachi H, et al. Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism. Biochem Biophys Res Commun. 2013; 431:203–209.